Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 9—September 2018
Research Letter

Symptomatic Dengue during Pregnancy and Congenital Neurologic Malformations

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Enny S. PaixãoComments to Author , Maria Glória Teixeira, Maria da Conceição N. Costa, Mauricio L. Barreto, and Laura C. Rodrigues
Author affiliations: London School of Hygiene and Tropical Medicine, London, United Kingdom (E.S. Paixão, L.C. Rodrigues); Instituto de Saúde Coletiva, Salvador-Bahia, Brazil (E.S. Paixão, M.G. Teixeira, M. da Conceição N. Costa, M.L. Barreto); Center of Data and Knowledge Integration for Health (CIDACS), Salvador-Bahia (M.L. Barreto, L.C. Rodrigues)

Cite This Article


Dengue virus infection during pregnancy increased the risk for any neurologic congenital anomaly in the infant by roughly 50% and for other congenital malformations of brain 4-fold. Our results show an association between dengue during pregnancy and congenital anomalies of the brain, suggesting that flaviviruses other than Zika virus are associated with such malformations.

Before the causal relationship between Zika virus and neurologic congenital anomalies (1), especially microcephaly (2), was established, no evidence associated flavivirus with congenital malformations in humans, although postnatal complications have been described (3). We investigated whether dengue virus (DENV) infection during pregnancy could be associated with neurologic defects in the infant at birth.

We conducted a population-based study using routinely collected data from live births and from women who were notified and confirmed to have DENV infection during 2006–2012 in Brazil, before the introduction of Zika virus. We probabilistically linked records of mothers of live births with records of dengue notification to identify women who were reported as having dengue during pregnancy. We excluded records with missing or implausible names, multiple pregnancies, and births in municipalities with no dengue notifications. We obtained ethics approval from Federal University of Bahia, Salvador, Brazil (CAAE: 26797814.7.0000.5030) and from London School of Hygiene and Tropical Medicine (Ethics Ref:10269).

In the matching process, we used name, age, and place of residence of the mother at time of delivery and notification. We included only links and nonlinks with a high degree of certainty. We validated the linkage process in a study that demonstrated 62% sensitivity (4).

We used an outcome definition of congenital malformation of the nervous system coded as Q00-Q07 in International Classification of Diseases, 10th Revision (ICD-10). We defined dengue as a confirmed case of DENV infection notified during a pregnancy that resulted in a live birth. We estimated the association between symptomatic dengue during pregnancy and neurologic congenital malformations using the Firth method to reduce the small sample bias in maximum-likelihood estimation.

The study parameters encompassed 16,103,312 live births. Neurologic congenital anomalies are rare; they occurred in 13,634 (0.08%) live births. Dengue during pregnancy increased the odds of a neurologic congenital anomaly by 50% (Table), but this result was not statistically significant (95% CI 0.97–2.27). We split the neurologic congenital defects into ICD-10 categories; the 95% CI around the estimated odds ratios (ORs) was not statistically significant in 7 categories, including microcephaly (OR 1.7, 95% CI 0.33–8.32). Two other types of neurologic congenital anomalies were >4 times more frequent in women who had DENV infection during pregnancy: other congenital malformations of spinal cord (OR 5.4, 95% CI 1.0–26.9) and other congenital malformations of brain (OR 4.5, 95% CI 1.7–11.3, which was statistically significant). We found no sign of space-time clusters or recording errors suggestive of a coding artifact in the 4 records of other congenital malformations of brain wherein the mother had DENV infection (Technical Appendix Table)

Symptoms of DENV infection occurred in the first trimester in 50% of patients. The specific diagnosis of those among the nonexposed group were congenital malformation of corpus callosum (9%; 81/943), holoprosencephaly (24%; 225/943), and septooptic dysplasia (0.6%; 6/943).

Our study showed an association between DENV infection during pregnancy and congenital anomalies of the brain. Congenital anomalies of the brain detectable by routine examination at birth are so rare (6/100,000 live births by our data) that it was necessary to assemble a cohort of >16 million live births to detect an effect of dengue; even then, we did not have sufficient power to confidently exclude associations with other neurologic abnormalities.

Because DENV infection had not been associated with congenital anomalies, there is no established biologic mechanism for its teratogenicity. However, there is evidence for postnatal neurotropism and virus isolation from brain tissue (5) and for dengue virus crossing the blood–brain and placental barriers (6,7). The pattern of anomalies we described has similarities with congenital Zika syndrome. Brain images and autopsies from infants with Zika and other infectious diseases have revealed abnormalities similar to those we described (8,9).

Our study has limitations inherent to the linkage process. Rigorous evaluation of the linkage process showed that it is unlikely to introduce bias and that it did not affect the magnitude of the association (4). Another potential limitation was diagnosis of DENV infection. In notifiable epidemics, not all cases are tested after the cause is established. DENV infection in Brazil is notified for the presence of clinical criteria, laboratory confirmation, or both. Only ≈30% of notified DENV infections are laboratory confirmed, which could lead to bias if unconfirmed cases are not dengue. However, a previous article found no difference in pregnancy outcomes for women with notified DENV infection with and without laboratory confirmation (10). We did not control for potential confounders, so confounders such as maternal illness or environmental exposures may have contributed to the association between dengue infection and neurologic malformations.

The association of symptomatic dengue during pregnancy and congenital anomalies of the brain in the infant, while not as high frequency as the linkage with Zika, opens the possibility of other flaviviruses causing congenital malformations and raises questions about policy implications. We recommend careful observation and recording of DENV infection in antenatal records and full investigation of live births with neurologic malformations, as well as animal and in vitro research of teratogenic effects of dengue.

Ms. Paixão is a PhD student at London School of Hygiene and Tropical Medicine. Her main research interests are congenital infections and use of routinely collected data.



E.S.P. is funded by the National Council of Technological and Scientific Development (CNPq), Brazil, and L.C.R. is partially funded by the European Union’s Horizon 2020 research and innovation program under Zika-PLAN grant agreement No. 734584. The funders of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author a contributions: E.S.P. carried out the analysis and wrote the first draft of the article. L.C.R. and M.G.T. conceived the study. C.N.C. and M.L.B. contributed to the study design and interpretation. All authors revised the manuscript and approved the final version.



  1. Rasmussen  SA, Jamieson  DJ, Honein  MA, Petersen  LR. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med. 2016;374:19817. DOIPubMedGoogle Scholar
  2. de Araújo  TVB, Rodrigues  LC, de Alencar Ximenes  RA, de Barros Miranda-Filho  D, Montarroyos  UR, de Melo  APL, et al.; investigators from the Microcephaly Epidemic Research Group; Brazilian Ministry of Health; Pan American Health Organization; Instituto de Medicina Integral Professor Fernando Figueira; State Health Department of Pernambuco. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis. 2016;16:135663. DOIPubMedGoogle Scholar
  3. John  CC, Carabin  H, Montano  SM, Bangirana  P, Zunt  JR, Peterson  PK. Global research priorities for infections that affect the nervous system. Nature. 2015;527:S17886. DOIPubMedGoogle Scholar
  4. Paixão  ES, Harron  K, Andrade  K, Teixeira  MG, Fiaccone  RL, Costa  MDCN, et al. Evaluation of record linkage of two large administrative databases in a middle income country: stillbirths and notifications of dengue during pregnancy in Brazil. BMC Med Inform Decis Mak. 2017;17:108. DOIPubMedGoogle Scholar
  5. Carod-Artal  FJ, Wichmann  O, Farrar  J, Gascón  J. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:90619. DOIPubMedGoogle Scholar
  6. Chaturvedi  UC, Dhawan  R, Khanna  M, Mathur  A. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol. 1991;72:85966. DOIPubMedGoogle Scholar
  7. Castanha  PMS, Braga  C, Cordeiro  MT, Souza  AI, Silva  CD Jr, Martelli  CM, et al. Placental transfer of dengue virus (DENV)–specific antibodies and kinetics of DENV infection-enhancing activity in Brazilian infants. J Infect Dis. 2016;214:26572. DOIPubMedGoogle Scholar
  8. Martines  RB, Bhatnagar  J, de Oliveira Ramos  AM, Davi  HP, Iglezias  SD, Kanamura  CT, et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet. 2016;388:898904. DOIPubMedGoogle Scholar
  9. Nunes  ML, Carlini  CR, Marinowic  D, Neto  FK, Fiori  HH, Scotta  MC, et al. Microcephaly and Zika virus: a clinical and epidemiological analysis of the current outbreak in Brazil. J Pediatr (Rio J). 2016;92:23040. DOIPubMedGoogle Scholar
  10. Paixão  ES, Costa  MDCN, Teixeira  MG, Harron  K, de Almeida  MF, Barreto  ML, et al. Symptomatic dengue infection during pregnancy and the risk of stillbirth in Brazil, 2006-12: a matched case-control study. Lancet Infect Dis. 2017;17:95764. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2409.170361

Original Publication Date: July 23, 2018

Table of Contents – Volume 24, Number 9—September 2018

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Enny S. Paixão, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK

Send To

10000 character(s) remaining.


Page created: August 16, 2018
Page updated: August 16, 2018
Page reviewed: August 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.